1. Home
  2. BHB vs RIGL Comparison

BHB vs RIGL Comparison

Compare BHB & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bar Harbor Bankshares Inc.

BHB

Bar Harbor Bankshares Inc.

HOLD

Current Price

$32.16

Market Cap

527.8M

Sector

Finance

ML Signal

HOLD

Logo Rigel Pharmaceuticals Inc.

RIGL

Rigel Pharmaceuticals Inc.

HOLD

Current Price

$26.59

Market Cap

628.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHB
RIGL
Founded
1887
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
527.8M
628.4M
IPO Year
1995
2000

Fundamental Metrics

Financial Performance
Metric
BHB
RIGL
Price
$32.16
$26.59
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$36.67
$45.67
AVG Volume (30 Days)
167.4K
360.8K
Earning Date
04-16-2026
03-03-2026
Dividend Yield
3.99%
N/A
EPS Growth
N/A
1867.68
EPS
2.31
19.48
Revenue
N/A
$294,282,000.00
Revenue This Year
$22.68
N/A
Revenue Next Year
$3.66
$12.75
P/E Ratio
$13.93
$1.34
Revenue Growth
N/A
64.15
52 Week Low
$26.43
$15.50
52 Week High
$36.05
$52.24

Technical Indicators

Market Signals
Indicator
BHB
RIGL
Relative Strength Index (RSI) 49.83 33.33
Support Level $28.38 $26.38
Resistance Level $32.60 $30.59
Average True Range (ATR) 0.96 1.03
MACD 0.12 0.13
Stochastic Oscillator 87.44 36.23

Price Performance

Historical Comparison
BHB
RIGL

About BHB Bar Harbor Bankshares Inc.

Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Share on Social Networks: